Skip to main content
Equibles

CIBC Asset Management Inc

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1021926 Toronto, A6
Back to UTHR Full portfolio

Position in UTHR

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$3,405,401
+$1,943,706 QoQ
Shares Held
6,285
+155.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#295
of 877 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CIBC Asset Management Inc holds $28,653,269 across 17 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (11.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 119,627 $8,596,396
2 TEVA
Teva Pharmaceutical Industries Ltd
 159,286 $5,396,609
3 VTRS
Viatris Inc
 255,729 $4,060,976
4 UTHR
UNITED THERAPEUTICS Corp
This page 		6,285 $3,405,401
5 NBIX
Neurocrine Biosciences Inc
 19,103 $3,219,619
6 BHC
Bausch Health Companies Inc.
 265,310 $1,307,978
7 HLN
Haleon plc
 60,500 $564,465
8 ELAN
Elanco Animal Health Inc
 15,695 $386,253

All Filings in UTHR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,405,401 6,285
2026-03-31 $1,461,695 2,465
2025-12-31 $1,031,021 2,116
2025-09-30 $681,635 1,626
2025-06-30 $480,161 1,671
2025-03-31 $516,043 1,674
2024-12-31 $563,838 1,598
2024-09-30 $549,350 1,533
2024-06-30 $489,929 1,538
2024-03-31 $299,554 1,304
2023-12-31 $286,736 1,304
2023-09-30 $294,534 1,304
2023-06-30 $289,403 1,311
2023-03-31 $292,043 1,304
2022-12-31 $325,921 1,172
2022-09-30 $365,158 1,744
2022-06-30 $410,956 1,744
2022-03-31 $335,676 1,871
2021-12-31 $404,285 1,871
2021-09-30 $335,197 1,816
2021-06-30 $299,614 1,670
2021-03-31 $279,340 1,670
2020-12-31 $249,998 1,647